Delgado-Minjares, K.M.; Martinez-Fong, D.; Martínez-Dávila, I.A.; Bañuelos, C.; Gutierrez-Castillo, M.E.; Blanco-Alvarez, V.M.; Cardenas-Aguayo, M.-d.-C.; Luna-Muñoz, J.; Pacheco-Herrero, M.; Soto-Rojas, L.O.
Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy. Int. J. Mol. Sci. 2021, 22, 11702.
https://doi.org/10.3390/ijms222111702
AMA Style
Delgado-Minjares KM, Martinez-Fong D, Martínez-Dávila IA, Bañuelos C, Gutierrez-Castillo ME, Blanco-Alvarez VM, Cardenas-Aguayo M-d-C, Luna-Muñoz J, Pacheco-Herrero M, Soto-Rojas LO.
Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy. International Journal of Molecular Sciences. 2021; 22(21):11702.
https://doi.org/10.3390/ijms222111702
Chicago/Turabian Style
Delgado-Minjares, Karen M., Daniel Martinez-Fong, Irma A. Martínez-Dávila, Cecilia Bañuelos, M. E. Gutierrez-Castillo, Víctor Manuel Blanco-Alvarez, Maria-del-Carmen Cardenas-Aguayo, José Luna-Muñoz, Mar Pacheco-Herrero, and Luis O. Soto-Rojas.
2021. "Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy" International Journal of Molecular Sciences 22, no. 21: 11702.
https://doi.org/10.3390/ijms222111702
APA Style
Delgado-Minjares, K. M., Martinez-Fong, D., Martínez-Dávila, I. A., Bañuelos, C., Gutierrez-Castillo, M. E., Blanco-Alvarez, V. M., Cardenas-Aguayo, M.-d.-C., Luna-Muñoz, J., Pacheco-Herrero, M., & Soto-Rojas, L. O.
(2021). Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy. International Journal of Molecular Sciences, 22(21), 11702.
https://doi.org/10.3390/ijms222111702